MENU
+Compare
VVOS
Stock ticker: NASDAQ
AS OF
Sep 26, 04:59 PM (EDT)
Price
$3.13
Change
-$0.22 (-6.57%)
Capitalization
23.41M

VVOS Vivos Therapeutics Forecast, Technical & Fundamental Analysis

Vivos Therapeutics Inc is a medical technology company... Show more

VVOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VVOS with price predictions
Sep 25, 2025

VVOS sees its Stochastic Oscillator climbs out of oversold territory

On September 24, 2025, the Stochastic Oscillator for VVOS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VVOS's RSI Oscillator exited the oversold zone, of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VVOS advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

VVOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VVOS as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VVOS turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

VVOS moved below its 50-day moving average on August 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VVOS crossed bearishly below the 50-day moving average on August 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VVOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VVOS entered a downward trend on September 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.110) is normal, around the industry mean (60.031). P/E Ratio (0.000) is within average values for comparable stocks, (36.944). VVOS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.677). VVOS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (1.746) is also within normal values, averaging (79.191).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VVOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VVOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
VVOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VVOS is expected to report earnings to fall 12.73% to -47 cents per share on November 12

Vivos Therapeutics VVOS Stock Earnings Reports
Q3'25
Est.
$-0.48
Q2'25
Missed
by $0.16
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.77
Q3'24
Beat
by $0.25
The last earnings report on August 19 showed earnings per share of -55 cents, missing the estimate of -38 cents. With 185.21K shares outstanding, the current market capitalization sits at 23.41M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
7921 Southpark Plaza
Phone
+1 844 672-4357
Employees
114
Web
https://www.vivos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIQT2.580.06
+2.39%
LiqTech International
MET81.621.34
+1.67%
MetLife
REKR1.760.01
+0.57%
Rekor Systems
BGC9.46-0.13
-1.36%
BGC Group
BBNX19.52-2.61
-11.79%
Beta Bionics Inc

VVOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VVOS has been loosely correlated with CSBTF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VVOS jumps, then CSBTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
-3.74%
CSBTF - VVOS
51%
Loosely correlated
N/A
BIOQ - VVOS
38%
Loosely correlated
N/A
COCH - VVOS
26%
Poorly correlated
+2.80%
SHC - VVOS
25%
Poorly correlated
-0.96%
BIO - VVOS
25%
Poorly correlated
-2.24%
More

Groups containing VVOS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
-3.74%
Medical/Nursing Services
industry (226 stocks)
22%
Poorly correlated
-0.15%
Health Services
industry (438 stocks)
17%
Poorly correlated
-0.03%